Media Trust Score88%

Benitec Biopharma Inc. Announces Pricing of $18 Million Underwritten Public Offering – StreetInsider

HAYWARD, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or “the Company”), a development-stage, …

  • You already voted!
  • Read More